- Country profiles
- Data dashboard
- Satellite Pages
- About us
- WHAT'S NEW
The purpose of this review is to examine existing approaches in policy, programming and implementation responses to school-related gender-based violence (SRGBV) in the Asia-Pacific region. It seeks to advance our knowledge and learning in this field, both in terms of what we know about the phenomenon and its impact on individuals, as well as how best to address it, including through education.
Keywords: gender, violence, discrimination, bullying, abuse, school
The latest HIV data from 27 countries in Asia and the Pacific compiled, analyzed and presented by the Data Hub.
The guide offers an insight into what Australia’s leading HIV organisations are doing, a detailed analysis of Australia’s response to HIV and AIDS since the start of the epidemic, and a guide of what to do in Melbourne during AIDS 2014 and beyond.
In March 2014, there were 498 new HIV Ab sero-positive individuals confirmed by the STD/AIDS Cooperative Central Laboratory (SACCL) and reported to the HIV and AIDS Registry. This is 35% higher compared to the same period last year (n=370 in 2013).
A Framework for Media Engagement on Human Rights, Sexual Orientation and Gender Identity in South Asia: Regional Framework, Literature Review and Country Case Studies provides direction for how men who have sex with men (MSM) and transgender communities should engage with the media, and how the media itself should leverage its influence to reduce stigma and discrimination, educate and raise awareness of human rights issues, and support strategies and programmes that improve the political, social and legal environments for MSM and transgender people in South Asia. The report includes case studies from Bangladesh, Nepal and India and provides recommendations for actions by programme managers working in South Asia for both managing media and for empowering communities to work more effectively with media.
Abundant evidence shows that harm reduction programmes can significantly reduce HIV transmission among people who inject drugs. Several countries are demonstrating the benefits of actively scaling up quality programmes that are based on human rights and public health needs.
This training toolkit has been developed by the International Drug Policy Consortium (IDPC) and the Eurasian Harm Reduction Network (EHRN) to build the capacity of civil society organisations for engaging with, and influencing, drug policy making processes.
This toolkit can be used by anybody wishing to deliver trainings and workshops on drug policy advocacy to their civil society partners and members. It covers the areas of drug policy, civil society advocacy and harm reduction, and is intended as a comprehensive menu of activities and content from which a facilitator can pick and choose the ones which best suit the context, audience and timeframe.
The objective of this report is to provide an analysis of the provisions in the proposed TPPA in order to obtain a clearer understanding of their implications. It is hoped that the report will also be a useful resource for other stakeholders in the public health field.
The report analyses the key negotiating issues in the USA’s proposals (widely considered to be the basic negotiation text for the TPPA) which are likely to have an impact on access to medicines and public health.
Analysis in this report is based on negotiation texts that were leaked and made available in the public domain in 2011 and 2012. The main texts include the USA’s proposals for chapters on intellectual property, on the regulation of pharmaceutical reimbursement programmes and on investment. It should be borne in mind that it may not be possible to provide a comprehensive examination of all relevant provisions or to assess fully how these provisions will impact and interact with other parts of the TPPA (which are not currently in the public domain). Moreover, as long as the negotiations are ongoing, the text may evolve and change.
Over the past decade, the Global Fund's presence in China has left behind a deeply mixed legacy. Although the Fund's money has made important contributions to China's fight against AIDS, TB, and malaria, as well as its domestic health governance in ideational, institutional, and policy domains, it is associated with uneven progress in grant performance, low value for money, unintended effects on civil society–building, and enduring challenges to scaling-up and sustainability.
Financing Global Health 2013 is the fifth edition of this annually produced report on global health financing. As in previous years, this report captures trends in development assistance for health (DAH) and government health expenditure as source (GHE-s). Health financing is one of IHME’s core research areas, and the aim of the series is to provide much-needed information to global health stakeholders. Updated GHE and DAH estimates allow decision-makers to pinpoint funding gaps and investment opportunities vital to improving population health.
This year, IHME made a number of improvements to the data collection and methods implemented to produce Financing Global Health estimates. Both government health expenditure and development assistance for health estimates were updated and enhanced in 2013